Short-Chain Fatty Acids (SCFAs)
Recipes
Foods
Biological Mechanisms and Implications
| Biological Target | Therapeutic Areas | Mechanism of Action |
|---|---|---|
| Gut Microbiome | Byproduct of fibre fermentation; supports intestinal barrier integrity; regulates immune responses; promotes synthesis of key neurotransmitters such as dopamine and serotonin | |
| Inflammation | Supports immune regulation and anti-inflammatory processes |
References
- ADHD group exhibiting significantly lower levels of key SCFAs, including acetic, propionic, isobutyric, isovaleric, and valeric acids Steckler et al. 2024
- A decreased microbial diversity (alpha diversity) has also been reported in ADHD Prehn-Kristensen et al. 2018
- Butyrate and other SCFA deficiencies have been linked to many neurological disorders including ADHD Fan et al. 2019
- Butyrate deficiencies linked to ASD and melatonin production, with relevance to ADHD populations due to symptom crossover Checa-Ros et al. 2021
- Butyrate has anti-inflammatory effects, potentially reducing neuroinflammation associated with ADHD
- Butyrate supports mitochondrial function, enhancing brain energy metabolism, which may help with cognitive impairments seen in ADHD Rose et al. 2018
- Butyrate aids in reducing cholesterol and neuroinflammation Cavaliere et al. 2022
- Propionate helps reduce neuroinflammation and enhance cognitive function while protecting the blood-brain barrier Hoyles et al. 2018
- Propionate stimulates secretion of norepinephrine and might influence dopamine regulation Mirzaei et al. 2021
- SCFAs support intestinal barrier integrity, regulate immune responses, and promote synthesis of key neurotransmitters such as dopamine and serotonin Silva et al. 2020
